03/04/2019
WPS Oncology Related LCD Updates
March 2019
March 2019 Local Coverage Determination (LCD)/Coverage Article Updates
The following is a list of the Local Coverage Determinations (LCDs) and Coverage Articles updated by WPS GHA for March 2019. Additional details about these updates are available in the
full article on our website.
New Policies/Articles
- Coding Article for MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test LCD L37913
- Coding Article for MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer LCD L37921
- MolDX: Bladder Tumor Marker FISH Billing and Coding Guidelines Update
- MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
- MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
- MolDX: Oncotype DX® Genomic Prostate Score Coding and Billing Article
Revised Policies/Articles
- MolDX: clonoSEQ® Assay for Assessment of Minimal Residual Disease (MRD) in Patients with Specific Lymphoid Malignancies
- MolDX: Coding and Billing for Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia
- MolDX: Oncotype DX® Genomic Prostate Score for Men with Favorable Intermediate Risk Prostate Cancer